astria therapeutics glp-1 receptor agonist weight management diabetes treatments Oral GLP-1-Based in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies Randomised trial comparing weight loss
Description
This article explains the gastrointestinal effects of GLP-1 therapy and provides practical guidance for managing bowel changes during treatment
The catheter tip was placed at the level of the aortic arch
[DOI] [PubMed] [Google Scholar] 186.Borah A.K., Ahmed S.A., Borah J.C
By inhibiting osteoblast differentiation of VSMCs, GLP-1RAs can ameliorate phosphate-induced vascular calcification, which is mediated by the AMPK/mTOR pathway or AMPK/receptor activator of nuclear factor kappa B ligand (RANKL), as occurs in the osteoblast differentiation of VSMCs [128, 129]
Drug design of GLP-1 receptor agonists: Importance of in silico methods
Li C, Luo J, Jiang M, et al
